Rossari Biotech Limited

NSE: ROSSARI

29

total announcements

ROSSARI.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 14 Oct 2026

Market Cap

₹2,364 Cr

P/E (TTM)

15.7

P/E (Forward)

12.7

EPS (TTM)

₹27.18

52W Low

₹375.00

52W High

₹690.30

Dividend Yield

0.12%

Beta

0.58

Price / Book

1.8

Debt / Equity

32.7

Revenue (TTM)

₹2,550 Cr

Gross Margin

29.53%

Operating Margin

7.89%

NSECopy of Newspaper Publication28 Jun 2026

Rossari Biotech Limited

Copy of Newspaper Publication

Rossari Biotech Limited has published a notice of its 17th Annual General Meeting and details of the e-voting facility in two newspapers, Financial Express and Loksatta, as required by the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
NSEUpdates27 Jun 2026

Rossari Biotech Limited

Updates

Rossari Biotech Limited has announced the dispatch of letters to non-email shareholders regarding the 17th Annual General Meeting (AGM) and the availability of the Integrated Annual Report for the Financial Year 2025-26. The AGM will be held on July 20, 2026, through video conferencing, and the report is available on the company's website and other platforms.

Read more →📎 1 attachment
NSEUpdatesESG27 Jun 2026

Rossari Biotech Limited

Updates

Rossari Biotech Limited has released its Business Responsibility and Sustainability Report for the Financial Year 2025-26, highlighting its commitment to sustainability and responsible business practices.

Read more →📎 1 attachment
NSEShareholders meetingResults27 Jun 2026

Rossari Biotech Limited

Shareholders meeting

Rossari Biotech Limited has announced the 17th Annual General Meeting (AGM) to be held on July 20, 2026, through video conferencing. The meeting will consider the adoption of audited financial statements, declaration of dividend, appointment of a director, and approval of related party transactions.

Read more →📎 1 attachment
NSECommencement of commercial production/operations▲ PositiveExpansion26 Jun 2026

Rossari Biotech Limited

Commencement of commercial production/operations

Rossari Biotech Limited has commenced commercial production/operations at its blending facility in Thailand, with an installed capacity of 5000 MTPA, as part of its expansion strategy to serve the Southeast Asian market.

Read more →📎 1 attachment
NSETrading Window25 Jun 2026

Rossari Biotech Limited

Trading Window

Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Read more →📎 1 attachment
NSECopy of Newspaper Publication19 Jun 2026

Rossari Biotech Limited

Copy of Newspaper Publication

Rossari Biotech Limited announced the publication of the notice for its 17th Annual General Meeting (AGM). The AGM is scheduled for Monday, July 20, 2026. This announcement, made in compliance with SEBI regulations, informs shareholders about the upcoming meeting. The notices were published in the Financial Express (English) and Loksatta (Marathi) Mumbai editions on June 19, 2026. Investors should note this routine corporate event to stay informed about company governance and the meeting's agenda.

Read more →📎 1 attachment
NSEUpdatesResults18 Jun 2026

Rossari Biotech Limited

Updates

Rossari Biotech Limited has announced the schedule of its 17th Annual General Meeting (AGM) to be held on July 20, 2026. The meeting will be conducted through video conference or other audio-visual means. The record date for determining entitlement and payment of dividend to members has been fixed as July 10, 2026. The company has also fixed July 13, 2026, as the cut-off date for remote e-voting and e-voting during the AGM.

Read more →📎 1 attachment
NSERecord DateDividend18 Jun 2026

Rossari Biotech Limited

Record Date

Rossari Biotech Limited has announced the record date for the purpose of final dividend as Friday, July 10, 2026, and the cut-off date for e-voting as Monday, July 13, 2026.

Read more →📎 1 attachment
← PreviousPage 2 of 2